tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Allarity Therapeutics Anticipates Nasdaq Compliance, Withdraws S-1 Filing

Allarity Therapeutics Anticipates Nasdaq Compliance, Withdraws S-1 Filing

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An announcement from Allarity Therapeutics, Inc. (ALLR) is now available.

Allarity Therapeutics, Inc. announced it expects to regain compliance with Nasdaq’s Stockholders’ Equity Requirement after determining its stockholder equity exceeds the minimum $2.5 million threshold. The company is now awaiting Nasdaq’s decision on its compliance status. Separately, Allarity has also withdrawn its Registration Statement on Form S-1, initially filed in October 2023, as indicated in a recent press release.

For a thorough assessment of ALLR stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1